Search
Allogene Therapeutics Inc
ALLOAdd to Watchlist
2.000USD
+0.040+2.04%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
690.31MMarket Cap
LossP/E TTM
Allogene Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Allogene Therapeutics Inc is 8.08, ranking 167 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.61, which is -70.01% below the recent high of -0.78 and -32.08% above the recent low of -3.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
